Manage episode 291144745 series 2591035
What if some people undergoing psychedelic assisted therapy rather have a picture of Manchester United or Britney Spears on the wall, instead of a buddha and yoga poses? Is this a question of class, just a different idea of spirituality and power objects? This is my favourite topic in the episode with Ben Sessa today. Dr. Ben Sessa is consultant psychiatrist, psychedelic therapist and chief medical officer at Awakn Life Sciences , UK’s first on-the-high-street provider of psychedelic-assisted psychotherapy. Awakn is researching, developing and delivering evidence-based psychedelic medicine to treat addiction and other mental health conditions, and is aiming to open 15 to 20 clinics across the UK and EU in the next 24 months. Patients will be able to self-refer or be referred by their GP (including NHS). Ben focuses on MDMA-assisted therapies, since the substance is further along in the research and legal processes then psilocybin.Though in the meantime, Ben and his team work also with Ketamine as a therapy tool. The need for psychedelic assisted therapy seems higher then ever. Ben tells me, 30 to 40 % of the British population is drinking in a harmful bracket now in the last 12 month of the pandemic. We talk about rather different ways of using psychedelics like ketamine for addiction, MDMA for obesity or psilocybin for anorexia, something Ben, as a fan of creative psychopharmacology, is interested in. We also address what happens, if depression and anti-depressants can become part your identity and how you might be able to get rid of your own old stories about yourself with the support of psychedelic assisted therapy.